Private Advisor Group, LLC Biomarin Pharmaceutical Inc Transaction History

Private Advisor Group, LLC

$14.8 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$87.74 - $117.27 $203,556 - $272,066	2,320 New	2,320 $225,000
Q3 2022 Oct 14, 2022	BUY	$82.16 - $96.94 $14,788 - $17,449	180 Added 6.34%	3,021 $256,000
Q2 2022 Jul 13, 2022	SELL	$71.48 - $86.85 $159,900 - $194,283	-2,237 Reduced 44.05%	2,841 $235,000
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $64,045 - $81,682	893 Added 21.34%	5,078 $449,000
Q3 2021 Oct 14, 2021	BUY	$74.77 - $85.47 $312,912 - $357,691	4,185 New	4,185 $323,000
Q1 2021 Apr 22, 2021	SELL	$74.73 - $90.69 $263,049 - $319,228	-3,520 Closed	0 $0
Q4 2020 Apr 01, 2021	SELL	$72.61 - $90.2 $55,474 - $68,912	-764 Reduced 17.83%	3,520 $309,000
Q3 2020 Nov 02, 2020	BUY	$71.87 - $131.03 $78,122 - $142,429	1,087 Added 34.0%	4,284 $326,000
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $8,273 - $12,918	104 Added 3.36%	3,197 $394,000
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $5,923 - $8,038	83 Added 2.76%	3,093 $261,000
Q4 2019 Feb 10, 2020	SELL	$64.27 - $86.37 $10,668 - $14,337	-166 Reduced 5.23%	3,010 $254,000
Q3 2019 Nov 13, 2019	SELL	$67.4 - $85.11 $82,362 - $104,004	-1,222 Reduced 27.79%	3,176 $214,000
Q2 2019 Aug 14, 2019	SELL	$80.35 - $93.9 $68,538 - $80,096	-853 Reduced 16.24%	4,398 $377,000
Q1 2019 May 13, 2019	BUY	$84.2 - $98.62 $50,435 - $59,073	599 Added 12.88%	5,251 $467,000
Q4 2018 Feb 11, 2019	SELL	$80.14 - $106.07 $40,230 - $53,247	-502 Reduced 9.74%	4,652 $396,000
Q3 2018 Nov 01, 2018	SELL	$93.92 - $105.72 $639,689 - $720,058	-6,811 Reduced 56.92%	5,154 $500,000
Q2 2018 Aug 09, 2018	BUY	$76.01 - $99.03 $909,459 - $1.18 Million	11,965 New	11,965 $1.13 Million
Q4 2017 Feb 07, 2018	SELL	$80.76 - $95.13 $332,004 - $391,079	-4,111 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$80.6 - $94.95 $88,498 - $104,255	-1,098 Reduced 21.08%	4,111 $390,000
Q2 2017 Aug 10, 2017	BUY	N/A	5,209	5,209 $468,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account